Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment
about
Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment
description
im September 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 06 September 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Design of a transdermal formul ...... les for osteoporosis treatment
@en
Design of a transdermal formul ...... les for osteoporosis treatment
@nl
type
label
Design of a transdermal formul ...... les for osteoporosis treatment
@en
Design of a transdermal formul ...... les for osteoporosis treatment
@nl
prefLabel
Design of a transdermal formul ...... les for osteoporosis treatment
@en
Design of a transdermal formul ...... les for osteoporosis treatment
@nl
P2093
P2860
P921
P356
P1476
Design of a transdermal formul ...... les for osteoporosis treatment
@en
P2093
Hiroko Otake
Noriaki Nagai
Yosuke Nakazawa
P2860
P304
P356
10.2147/IJN.S173216
P407
P577
2018-09-06T00:00:00Z